View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter's Weekly Newsletter

In this episode, Peter explores one of the most foundational topics underlying nearly everything discussed on the podcast: how to think scientifically. Framed as an introspective deep dive, he examines why scientific thinking is inherently difficult for humans, the cognitive biases and tendencies that make it challenging to separate belief from evidence, and why these challenges are even more consequential in today's environment saturated with misinformation. He also offers a framework for improving our ability to evaluate claims, question assumptions, and identify a personal panel of experts, providing listeners with practical tools to become more disciplined and effective thinkers.

We discuss:

• Topics to be covered and goals for this episode [2:00];
• Scientific thinking: hypotheses, uncertainty, and the process of ruling out explanations [3:45];
• How scientific knowledge differs from mathematical proof: useful approximations, evolving evidence, and acting under uncertainty [8:00];
• Why scientific thinking is difficult: evolution, social instincts, and the need for deliberate practice [13:30];
• Systems and tools designed to correct human bias [18:15];
• How to think scientifically pt. 1: Notice when you're feeling certain [20:30];
• How to think scientifically pt. 2: Judge the process, not just the conclusion [23:00];
• How to think scientifically pt. 3: Notice when identity is shaping your beliefs [28:15];
• How to think scientifically pt. 4: Don't confuse criticism with understanding [33:45];
• How to think scientifically pt. 5: Outsource your thinking carefully [36:15];
• Evaluating who to trust: incentives, consensus, and red flags in scientific credibility [45:15];
• Science as a self-correcting system: why updating with evidence is a strength, not a weakness [49:00];
• The key principles of scientific thinking, and a practical framework for evaluating claims and improving judgment [50:45]; and
• More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter's Weekly Newsletter

In this episode, Peter takes a deep dive into prostate cancer screening, explaining why advanced and metastatic diagnoses continue to rise despite the availability of screening tools, and what can be done to reverse this trend. He breaks down what PSA actually measures and why it is far more informative when tracked over time rather than interpreted as a single value, and he explores how tools like MRI, PSA density, PSA velocity, and improved biopsy techniques can both reduce unnecessary procedures and improve the detection of aggressive cancers. Peter also discusses the role of active surveillance in avoiding overtreatment for low-risk cases, examines the flawed evidence that has historically been used to argue against PSA screening, and highlights how medications like finasteride can suppress PSA levels and potentially mask warning signs if not properly accounted for. Ultimately, he makes a compelling case for the importance of regular PSA testing as a key strategy in the effort to eliminate prostate cancer mortality.

We discuss:

• The failure of current prostate cancer screening guidelines, and the rise in advanced disease despite available tools [2:30];
• PSA screening fundamentals: benefits, harms, and the guideline shift driven by overdiagnosis concerns [5:30];
• The impact of reduced PSA screening: rising rates of late-stage prostate cancer and worsening population-level outcomes [12:00];
• How modern screening practices use PSA trends, MRI, and new imaging advances to improve accuracy and reduce unnecessary procedures [15:00];
• Advances in prostate biopsy: transperineal approach improves safety and cancer detection [23:00];
• Reducing overtreatment: Gleason scoring and active surveillance in modern prostate cancer care [25:30];
• Reevaluating PSA screening guidelines: how flaws in the PLCO trial undermine the evidence used to argue against PSA screening [29:45];
• Prostate cancer screening today: improved tools, flawed guidelines, and preventable mortality [33:45];
• How finasteride and similar drugs suppress PSA levels and can lead to missed or delayed prostate cancer diagnoses if not properly accounted for [38:00];
• The optimistic future of prostate cancer: modern screening advances and the potential to reduce mortality [43:15]; and
• More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube